Abstract
Since loss of function mutations of PINK1 lead to early onset Parkinson's disease, there has been growing interest in the discovery of small molecules that amplify the kinase activity of PINK1. We herein report the design, synthesis, serum stability, and hydrolysis of four kinetin riboside ProTides. These ProTides, along with kinetin riboside, activated PINK1 in cells independent of mitochondrial depolarization. This highlights the potential of modified nucleosides and their phosphate prodrugs as treatments for neurodegenerative diseases.
Original language | English |
---|---|
Pages (from-to) | 3518-3524 |
Number of pages | 7 |
Journal | Journal of Medicinal Chemistry |
Volume | 60 |
Issue number | 8 |
Early online date | 21 Mar 2017 |
DOIs | |
Publication status | Published - 27 Apr 2017 |